Newsroom

News

Acquiring external funding is an integral part of any young scientist’s path towards an independent research career. Such additional funds not only make their own scientific success visible, but also give them freedom to implement new and possibly riskier project ideas. One funding instrument that focuses on supporting early stage researchers is the Klaus-Tschira-Boost-Fund. In the current round of applications, 15 out of more than 300 applicants were selected to receive funding of up to 120,000 Euros each – amongst them the junior researchers Mariia Nesterkina and Florian Hubrich from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. As so-called “Boost Fellows”, Mariia Nesterkina and Florian Hubrich benefit not only from the funding itself, but also from a series of workshops on career development and gain access to extensive career counseling and coaching services. The funded projects are set to start between April and October 2025 and will run for 24 months.

01.04.2025

HIPS

Teaser for the podcast episode with Martin Korte

News

How do viruses and bacteria affect our cognitive abilities? What role do they play in neurodegenerative diseases like Alzheimer’s and dementia? And how can we protect our brain in the long term? In this episode of the HZI podcast InFact, Prof. Martin Korte, head of the research group “Neuroinflammation and Neurodegeneration” at the Helmholtz Centre for Infection Research (HZI), discusses the links between infections, the immune system, and the brain.

26.03.2025

HZI Campus

Illustration of a large monocyte surrounded by smaller red blood cells

News

Not only does our body change with age, but so does our immune system. A recent study led by the Centre for Individualised Infection Medicine (CiiM) shows exactly how immune cells age and how infections and vaccinations can influence this process. The CiiM is a joint initiative of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Using a big data approach, the researchers have developed a computer model called the “Single-Cell Immune Aging Clock”, which can be used to determine aging processes within individual immune cells. The scientists are making the innovative aging clock freely available for further research. They hope that it will serve as a useful tool to better understand the aging processes of the immune system, particularly with the context of infectious diseases and immune disorders. The study has been published in the journal Nature Aging.

19.03.2025

CiiM

Interview

Bushmeat, the meat of wild animals hunted for food, is consumed across cultures and considered a delicacy in most parts of the world. Especially in sub-Saharan Africa, it still represents a major fraction of the proteins consumed. However, the close contact between humans and diverse tropical wildlife species — potentially harboring a wide variety of pathogens — poses a significant risk for the transmission of zoonotic diseases. The project "BehaviorChange: Co-creating and evaluating behavioral change interventions for reducing the zoonotic risk associated with wildlife consumption" aims to characterize the zoonotic risks associated with bushmeat consumption in Côte d’Ivoire and Liberia, and to understand its socio-economical drivers.

14.03.2025

HIOH

News

Regarding the current reporting on the origin of the coronavirus SARS-CoV-2, Prof. Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), makes the following statement: “Based on the data published to date, it can be assumed that the transmission to humans took place via intermediate hosts (e.g. animal farms), as the contacts and risks are much higher there. This data has been published in various WHO reports and relevant peer-reviewed scientific publications. If there is now other and new data that supports an origin in the laboratory, then that is a different picture. We now have to wait until this data has been examined and reviewed by experts.”

13.03.2025

HIOH

Interview

Dr Natalia Torow researches the immune system of newborns, seeking to understand how it responds to pathogens and vaccinations to better prevent early-life infections. Since 2024, she has led the junior research group "Early Life Immunity" at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, introducing a new research focus to the institution. In this interview, she discusses the neonatal immune system’s "silent mode," her goal of optimizing oral vaccines, and how she balances life as a researcher with family responsibilities.

06.03.2025

HZI Campus

Back to the first page
...
13
14
15
16
...
150

HZI in the media

Beisel at Germany's Helmholtz Institute for RNA-based Infection Research in Würzburg and Dirk Heinz at the Helmholtz Center for Infection

07.01.2026

News Medical

... basierte Infektionsforschung (HIRI) in Würzburg nachweisen. Gemeinsam mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung ...

07.01.2026

DeutschesGesundheitsPortal

consisting of Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, and the Leibniz Institute in

07.01.2026

Trading View

... haben nun die Studienautoren vom HIRI ‒ einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

02.01.2026

Biermann Medizin

... bis zur Medikamentenentwicklung", sagt Josef Penninger, wissenschaftlicher Geschäftsführer des HZI und Leiter der Abteilung Innovative ...

30.12.2025

Tagesschau

Erkrankungen. Eine Arbeitsgruppe des TWINCORE Helmholtz Zentrum für Infektionsforschung ( HZI ) und der Medizinischen Hochschule Hannover ( ...

30.12.2025

Deutsches Ärzteblatt

Forschungsteam um Tobias Gulder, Abteilungsleiter am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), ist es ...

29.12.2025

Biermann Medizin

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

29.12.2025

Das PTA Magazin

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Forschende vom Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

17.12.2025

Verband Deutscher Biologen e.V.

Finanzierungsmöglichkeiten fehlen.

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025

MedMedia

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.